Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

News Daily News

CABG and PCI Comparable in ACS Patients With Left Main CAD

Michael O'Riordan

June 06, 2023

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Conference News AHA 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Shelley Wood

November 15, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Daily News

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Michael O'Riordan

May 15, 2020

News Daily News CRT 2020

Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease

Michael O'Riordan

March 04, 2020

News Daily News

CTO PCI: Lower Success, More Complications vs Other Complex PCI

Yael L. Maxwell

November 13, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

News Conference News CRT 2019

CABG vs PCI in Left Main Disease: The Debate Continues

Yael L. Maxwell

March 12, 2019

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

News Daily News

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

Shelley Wood

July 21, 2017

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Conference News

SYNTAX Left Main: PCI Provides Similar Angina Relief to CABG at Lower Cost

Caitlin E. Cox

February 15, 2011

Advertisement

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

CABG and PCI Comparable in ACS Patients With Left Main CAD

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Meta-analysis Shows Similar 5-Year Mortality for PCI, CABG in Left Main Disease

CTO PCI: Lower Success, More Complications vs Other Complex PCI

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

CABG vs PCI in Left Main Disease: The Debate Continues

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Live From Denver: TCT 2017, Day One

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

SYNTAX Left Main: PCI Provides Similar Angina Relief to CABG at Lower Cost

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content